Drug
Ribavirin clinical trials
Also written RBV, Copegus, Rebetol and SCH 18908.
- studies test it
- 452
- open now
- 3
- in phase 3
- 153
- first study started
- 1997
Keep track of what changes. Save the Ribavirin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
437 studies that test it; most in 2012 (45)
| Year | Studies |
|---|---|
| 1997 | 2 |
| 1998 | 2 |
| 1999 | 2 |
| 2000 | 3 |
| 2001 | 7 |
| 2002 | 12 |
| 2003 | 20 |
| 2004 | 20 |
| 2005 | 22 |
| 2006 | 17 |
| 2007 | 30 |
| 2008 | 13 |
| 2009 | 24 |
| 2010 | 20 |
| 2011 | 41 |
| 2012 | 45 |
| 2013 | 36 |
| 2014 | 40 |
| 2015 | 31 |
| 2016 | 25 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 34
- Phase 2
- 171
- Phase 3
- 153
- Phase 4
- 96
- No phase
- 26
What it is tested for
Each study’s main condition, where its own words name it.
- Hepatitis C
- 138
Who runs them
Industry 258 · Other 194
Merck Sharp & Dohme LLC (37) · Gilead Sciences (37) · Hoffmann-La Roche (32) · AbbVie (27) · National Institute of Allergy and Infectious Diseases (NIAID) (21) · Bristol-Myers Squibb (18) · Vertex Pharmaceuticals Incorporated (17) · AbbVie (prior sponsor, Abbott) (10)
Often tested with
Tested in the same studies.
Peginterferon alfa-2a (100) · Sofosbuvir (42) · Peginterferon alfa-2b (41) · Ritonavir (32) · Telaprevir (30) · Dasabuvir (28) · Paritaprevir (26) · Ombitasvir (24)
Studies
Open first, then newest update. How each study uses Ribavirin is read from its arms, and is right about nine times in ten.
Testing it · 452
- ISTH/ANRS 0409s INTEGRATE Lassa Fever StudyRecruitingPhase 2/3Irrua Specialist Teaching HospitalNCT06212336Written as Ribavirin
- Assessing Antiviral Treatments in Early Symptomatic RSVRecruitingPhase 2University of OxfordNCT06488300Written as Ribavirin
- UMIT-1 Trial Favipiravir & Ribavirin for the Treatment of CCHFRecruitingPhase 1/2Liverpool School of Tropical MedicineNCT05940545Written as Ribavirin
- Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic FeverSuspendedNot applicableU.S. Army Medical Research and Development CommandNCT02483260Written as Ribavirin
- Treatment of Hemorrhagic Fever With RibavirinSuspendedPhase 2U.S. Army Medical Research and Development CommandNCT04283513Written as Virazole
- Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With SofosbuvirCompletedPhase 2ANRS, Emerging Infectious DiseasesNCT02647632Written as Ribavirin
- Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected PatientsCompletedPhase 2University Hospital, BordeauxNCT00221650Written as Ribavirin
- Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)CompletedPhase 2ANRS, Emerging Infectious DiseasesNCT02107365Written as Ribavirin
- Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver TransplantationCompletedPhase 2French National Agency for Research on AIDS and Viral HepatitisNCT01463956Written as Ribavirin
- Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin RegimenCompletedPhase 2ANRS, Emerging Infectious DiseasesNCT01332955Written as Ribavirin
- Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based TherapyCompletedPhase 3Tanabe Pharma CorporationNCT00781274Written as Ribavirin
- Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected PatientsCompletedPhase 3Tanabe Pharma CorporationNCT01466192Written as Ribavirin
- Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis CCompletedPhase 3Tanabe Pharma CorporationNCT01753557Written as RBV
- A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis CCompletedPhase 1Tanabe Pharma CorporationNCT00630058Written as MP-424(H), PEG-IFN-a-2b, RBV
- Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based TherapyCompletedPhase 3Tanabe Pharma CorporationNCT00780910Written as Ribavirin
- Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected PatientsCompletedPhase 3Tanabe Pharma CorporationNCT01468584Written as Ribavirin
- Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)CompletedPhase 3Tanabe Pharma CorporationNCT01753570Written as RBV(24 weeks)
- HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /RibavirinTerminatedPhase 3Anna CrucetaNCT01718301Written as Ribavirin
- Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAMCompletedPhase 2University Hospital, LimogesNCT00199719Written as Ribavirine
- Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer PatientsTerminatedPhase 1/2Jewish General HospitalNCT01309490Written as Ribavirin
See all 452 studies that test Ribavirin →
Given in every arm · 194 — Ribavirin is usual care beside what is tested
- LAssa Fever Adjunct Treatment With DEXamethasoneRecruitingPhase 2Bernhard Nocht Institute for Tropical MedicineNCT06222723Written as Ribavirin
- Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe FibrosisCompletedPhase 2French National Agency for Research on AIDS and Viral HepatitisNCT00148837Written as Peg-interferon alpha 2b + Ribavirin(drug)
- Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCCCompletedPhase 3National Hepatology & Tropical Medicine Research InstituteNCT02771405Written as Ribavirin
- Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis CCompletedPhase 3Tanabe Pharma CorporationNCT00780416Written as Ribavirin
- Pembrolizumab (MK-3475) in Hepatocellular CarcinomaCompletedPhase 2M.D. Anderson Cancer CenterNCT02940496Written as Ribavirin
- Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.WithdrawnPhase 3Fundacion Clinic per a la Recerca BiomédicaNCT02890719Written as Ribavirin 1200 mg/day
- A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis CCompletedPhase 1/2HanAll BioPharma Co., Ltd.NCT01194037Written as Ribavirin
- Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)CompletedPhase 2Merck Sharp & Dohme LLCNCT01353911Written as Ribavirin
- Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)TerminatedPhase 2Merck Sharp & Dohme LLCNCT01440595Written as Ribavirin (RBV)
- Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)TerminatedPhase 2Merck Sharp & Dohme LLCNCT02613403Written as Ribavirin
- Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AMLCompletedPhase 2Sarit AssoulineNCT02073838Written as Ribavirin
- Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive ParticipantsCompletedPhase 2Alexion Pharmaceuticals, Inc.NCT01180790Written as Ribavirin
- Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIVTerminatedPhase 3Bristol-Myers SquibbNCT01866930Written as Ribasphere (RBV)
- Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)CompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00078403Written as Ribavirin
- High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCVCompletedPhase 3Foundation for Liver ResearchNCT00381953Written as Ribavirin
- A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus InfectionCompletedPhase 2AbbVie (prior sponsor, Abbott)NCT01685203Written as Ribavirin (RBV)
- A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)CompletedPhase 2AbbVieNCT01995071Written as Ribavirin (RBV)
- Directly Observed Therapy for HCV in Chennai, IndiaCompletedPhase 2Johns Hopkins Bloomberg School of Public HealthNCT02541409Written as Ribavirin
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)CompletedPhase 3Merck Sharp & Dohme LLCNCT01023035Written as Ribavirin (RBV)
- The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160)CompletedPhase 3Merck Sharp & Dohme LLCNCT01425203Written as Ribavirin
Showing 20 of 194.
As the comparator · 21 — what is tested is compared with Ribavirin
- ARN-75039 Lassa Fever Treatment in West AfricaSuspendedPhase 2Arisan Therapeutics, Inc.NCT07419373Written as Intravenous ribavirin
- Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa FeverCompletedPhase 2Bernhard Nocht Institute for Tropical MedicineNCT04907682Written as Ribavirin iv
- Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral ActivityStatus unknownPhase 3Ottawa Hospital Research InstituteNCT03759782Written as Ribavirin
- A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus InfectionCompletedPhase 3AbbVieNCT02723084Written as ribavirin (RBV)
- Effect of Recombinant Human Interferon α-2b Spray on HerpanginaCompletedPhase 4Children's Hospital of Fudan UniversityNCT03266601Written as Ribavirin
- Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth DiseaseCompletedPhase 4Children's Hospital of Fudan UniversityNCT02328651Written as Ribavirin
- A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV InfectionCompletedPhase 3Egyptian Liver HospitalNCT03186313Written as Sofosbuvir + Daclatasvir + Ribavirin
- Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV InfectionCompletedPhase 2/3Egyptian Liver HospitalNCT02483156Written as Ribavirin (RBV) 1000 mg - splitted on 2 doses daily - 600 mg on morning and 400 mg on evening
- The SIM-SOF Trial for Hepatitis CCompletedPhase 4Center For Hepatitis C, Atlanta, GANCT02168361Written as Ribavirin
- Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCVCompletedPhase 2Cairo UniversityNCT02690103Written as Ribavirin
- A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV SubjectsCompletedPhase 3Bristol-Myers SquibbNCT01718145Written as Ribavirin
- A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis CCompletedPhase 2Beijing Kawin Technology Share-Holding Co., Ltd.NCT01908335Written as Pegasys /RBV
- Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C InfectionCompletedPhase 2GlobeImmuneNCT00606086Written as Pegylated Interferon and Ribavirin
- Effectiveness Study of Integrative Treatment for Pediatric PneumoniaCompletedNot applicableLiaoning University of Traditional Chinese MedicineNCT02069665Written as Ribavirin Injection
- Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV PatientsCompletedPhase 2TransgeneNCT01055821Written as pegylated interferon and ribavirin
- A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian SubjectsCompletedPhase 3EMD SeronoNCT00249860Written as Ribavirin plus Interferon-beta-1a
- A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C InfectionWithdrawnPhase 3Boehringer IngelheimNCT01608737Written as PegIFN/RBV
- Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)CompletedPhase 2Bausch Health Americas, Inc.NCT00446134Written as Ribavirin
- Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHCCompletedPhase 4Brooke Army Medical CenterNCT00207363Written as Ribavirin, Peg interferon alfa 2b
- To Study the Efficacy and Safety of Renessans in Chronic HCV PatientsStatus unknownPhase 3MTI Medical Private Limited, PakistanNCT01463592Written as Interferon Alfa-2b AND RIBAVIRIN
Showing 20 of 21.
Codes
What other systems call Ribavirin · ClinicalTrials.gg INT008159
- MeSH (NLM) D012254RibavirinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 49717AWG6KRIBAVIRINConfirmed FDA, NLM, Wikidata
- RxNorm 9344Confirmed FDA, Wikidata
- Wikidata Q421862ribavirinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C807RibavirinOne source FDA
- DrugBank DB00811One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012254 | Ribavirin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 49717AWG6K | RIBAVIRIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9344 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421862 | ribavirin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C807 | Ribavirin | One source FDA |
| DrugBank | DB00811 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.